Fred Tobia

Fred Tobia has a diverse background in regulatory affairs, quality compliance, and clinical affairs. Fred currently serves as the VP of Regulatory and Quality Compliance at Hero since April 2022. Prior to that, they worked as a Principal at MDQRC Consultants starting from April 2020. From September 2018 to April 2020, they held the position of VP of Regulatory, Clinical & Quality at Cognito Therapeutics. Before that, they served as the VP of Clinical & Regulatory Affairs at Illuminoss Medical Inc. from November 2013 to 2018. Fred also has experience as the Director of Regulatory and Clinical Affairs at Aptiv Solutions from July 2011 to November 2013. Additionally, they worked as the Vice President of Clinical/Regulatory at NMT Medical from 2005 to 2011, and as the VP of Clinical, Quality, and Regulatory at Seacoast Technologies from 2004 to 2005. Earlier in their career, they held the role of Director of QA/RA at CareStat, Inc. from 2002 to 2004, and Director of RA/CA/QA at UroMed Corp from 1996 to 2002.

Fred Tobia attended McGill University from 1983 to 1984, where they studied Biology. Fred then transferred to Providence College and pursued a degree in Biology from 1984 to 1987. Following this, Fred Tobia enrolled at the Harvard T.H. Chan School of Public Health, where they attended from 1988 to 1991. No specific degree or field of study is provided for their time at Harvard.